Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples

NCT05570266 is registered in ClinicalTrials.gov with Nalagenetics Pte Ltd as lead sponsor.

NCT NCT05570266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05570266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples
Lead sponsor
Nalagenetics Pte Ltd
Phase
Observational
Overall status
Completed
Start date
October 13, 2020
Completion date
May 25, 2023
Enrollment
322 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer